Skip to content

Gender Dysphoria and Transition

Gender Dysphoria and Transition: Testimony From Transgender People

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04265885
Acronym
DyGePeT
Enrollment
10
Registered
2020-02-12
Start date
2020-10-31
Completion date
2021-09-30
Last updated
2020-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gender Dysphoria

Brief summary

Persons with gender dysphoria present the difficulties of access to health care. Little time is devoted to education of health professionals about the care of transgender persons. According to the proposal of the French Ministry of Social Affairs and Health there is a need to increase knowledge in this area and to improve the care of transgender people including prevention and screening. Similarly, little is known about social and medical needs of the transgender population. This project proposes to illustrate gender dysphoria through testimonies of transgender people with the aim to increase the investigator's understanding aout the needs and the desires of this population and to describe the process of medical and social transition.

Interventions

OTHERcollection of testimonies from transgender people

guided interview

Sponsors

University of Lorraine
CollaboratorOTHER
Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
FAMILY_BASED
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Person affiliated to a social security system * Person having received complete information on the organisation of the research and having signed the informed consent * Person having carried out a prior clinical examination adapted to the research * Age\> 18 years * Diagnosis of gender incongruence (dysphoria) according to the international classification of diseases, revision 11

Exclusion criteria

* Severe, uncontrolled psychiatric or somatic illness * Substance and alcohol addiction * Pregnancy

Design outcomes

Primary

MeasureTime frame
Illustrate the real-life experiences of transgender people4 months

Contacts

Primary ContactEva Feigerlova, MD, PhD
e.feigerlova@chru-nancy.fr+33(0)83155032

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026